Off campus

Growing Houston coworking space announces plans for new Galleria-area satellite

The Cannon – Post Oak will open on January 21, which is well ahead of its new space in West Houston that's currently under construction. Pictured is a rendering for the West Houston space. Courtesy of The Cannon

While The Cannon is currently in the midst of construction on its 120,000-square-foot space in West Houston, the coworking space has announced a new office that will open ahead its main campus.

The Cannon – Post Oak, located at 675 Bering Drive (near the Woodway Drive intersection), will open on January 21. The Cannon partnered with Houston-based commercial real estate group Griffin Partners to open the new location just west of The Galleria.

"The size and scale of Houston can create challenges for entrepreneurs and small businesses to make the trip out to our main campus, so we've recognized that it's increasingly important for us to grow our presence across the city and create more accessible solutions for Houston's entrepreneurs," says Founder and CEO Lawson Gow, son of David Gow, owner of InnovationMap's parent company Gow Media.

"We're especially thrilled to partner with an innovative group like Griffin Partners who shares our entrepreneurial spirit and dedication to Houston."

Griffin Partners has a portfolio of 4.5 million square feet Arizona, Colorado, North Carolina, and Texas valued at over $750 million. The team is similarly excited, as the partnership marks the company's first foray into coworking space.

"We are excited to work with The Cannon and expand our offerings to include coworking space, allowing us to reach a brand new population and create new opportunities for Houston's entrepreneurs, small businesses and startups," says Edward Griffin, the company's president and CEO.

Community members from the off-campus site will be a part of The Cannon's overall community and will have access to Cannon events and can even have access to the main campus for a few days a month. The Cannon has various membership options.

The floor plan shows 16 offices available for renting, as well as both open and dedicated desks in a shared area. There's also a kitchen, one conference room, and two smaller meeting rooms in the floor plan. According to the website, members will have 24/7 access, a gaming room, and unlimited coffee and tea.


Via thecannonhouston.com

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News